Fig. 2From: Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the USAF detection rates in ICM and SoC—all patients. Notes: Both ICM and SoC detection curves are modelled based on analysis of the REVEAL AF trial dataset (5). The AF burden is extrapolated from the end of the 30-month study and the end of the battery life at 36 months, using a linear extrapolation from month 3 to month 30 (3.9% per 3-month cycle). Abbreviations: AF: atrial fibrillation; ICM: insertable cardiac monitor; SoC, standard of careBack to article page